What is Jecho Laboratories?
Founded in 2013, Jecho Laboratories, Inc. is a research and development entity dedicated to pioneering innovative therapeutic biologics aimed at combating complex cancers and infectious diseases. The company's diverse product portfolio encompasses antibodies, cytokines, oncolytic viruses, and other advanced biological molecules. Jecho Laboratories has garnered recognition as a top workplace and innovator within Frederick, Maryland, emphasizing a commitment to diversity and inclusion alongside competitive employee compensation and benefits.
How much funding has Jecho Laboratories raised?
Jecho Laboratories has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Jecho Laboratories
PPP
Public-Private Partnership
What's next for Jecho Laboratories?
The substantial capital infusion, particularly the recent strategic investment, positions Jecho Laboratories for accelerated growth and the scaling of its therapeutic pipeline. This late-stage funding is indicative of strong investor confidence in the company's R&D trajectory and its potential to deliver impactful solutions in oncology and infectious disease treatment. Future endeavors will likely focus on advancing clinical trials, expanding manufacturing capabilities, and potentially forging strategic partnerships to bring their innovative biologics to market.
See full Jecho Laboratories company page
